Related Experiment Videos
Immune cell signaling defects in lupus: activation, anergy and death
1Uniformed Services University of the Health Sciences, Dept of Medicine, Bethesda, MD 20814, USA. gtsokos@usa.net
Abstract:
Recent studies have identified novel aberrations in antigen receptor-mediated signaling events in lymphocytes from patients with systemic lupus erythematosus. Here, we propose that in lupus lymphocytes, the receptor-mediated increase in protein tyrosine phosphorylation and cytoplasmic free Ca2+ responses, along with T-cell receptor zeta chain deficiency, might explain the previously described diverse and conflicting immunoregulatory defects in human lupus.
Insights
Novel signaling defects in lymphocytes, including altered protein tyrosine phosphorylation and calcium responses, alongside T-cell receptor zeta chain deficiency, may explain immune system dysregulation in systemic lupus erythematosus patients.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
- Previous research has noted diverse and conflicting immunoregulatory defects in human lupus.
Purpose of the Study:
- To investigate novel aberrations in antigen receptor-mediated signaling events in lymphocytes from SLE patients.
- To propose a unifying explanation for the observed immunoregulatory defects in lupus.
Main Methods:
- Analysis of antigen receptor-mediated signaling pathways in lymphocytes.
- Assessment of protein tyrosine phosphorylation and cytoplasmic free Ca2+ responses.
- Evaluation of T-cell receptor zeta chain expression.
Main Results:
- Identification of novel aberrations in signaling events in lymphocytes from SLE patients.
- Observed increased protein tyrosine phosphorylation and cytoplasmic free Ca2+ responses.
- Detected T-cell receptor zeta chain deficiency in lupus lymphocytes.
Conclusions:
- The identified signaling aberrations, including increased phosphorylation, calcium responses, and T-cell receptor zeta chain deficiency, may collectively explain the immunoregulatory defects in systemic lupus erythematosus.